Michal Ursiny, MD
About Procedures Patient Resources Reviews Book Consultation
Home/Prostate Cancer Care
Prostate Cancer Care

Prostate cancer care in Maine.

Full-spectrum prostate cancer care — from the first elevated PSA through definitive treatment and the long-term management of advanced disease. Michal Ursiny, MD is a Harvard- and Massachusetts General Hospital-trained urologic oncologist practicing in southern Maine, caring for patients throughout Maine and New Hampshire — from the Seacoast and central New Hampshire to Conway and the White Mountains.

One urologic oncologist across the whole journey.

Prostate cancer is not one story. Some men do years of active surveillance and never need treatment. Some are cured by a single course of surgery or radiation and never see prostate cancer return. Some require a combination of therapies over time. And for some, the disease cannot be cured — but with today's therapies, it can often be controlled for many years. In every version, what helps most is having one doctor who knows the whole story — the biopsy, the surgery, the imaging, the medications, the side effects, the priorities — and who follows it across the years.

That is the practice Dr. Ursiny runs. He performs the operation when an operation is the right answer; he prescribes and manages hormonal therapy when that is the right answer; he orders PSMA PET when staging or recurrence calls for it. The same physician is in the operating room, on the phone, and in the follow-up clinic over time. There is no handing off across departments.

That kind of continuity is harder to find than it should be. Most centers split prostate cancer across multiple specialists — urology for the surgery, medical oncology for the hormones, radiation oncology for the radiation, with shifting faces and competing schedules. The practice here is built around the opposite: one face, one phone number, one plan that evolves with the disease.

Where you are in the journey.

Click through to the part that applies to you right now.

Diagnosis

An elevated or rising PSA, an abnormal prostate MRI, or a finding on exam. MRI-guided biopsy — most often done comfortably in the office — confirms whether cancer is present and how aggressive it is.

Prostate biopsy →

Localized cancer

Cancer is confined to the prostate. Many low-risk cancers are safely watched. For cancers that warrant treatment, high-volume robotic prostatectomy is one of two well-established curative options.

Robotic prostatectomy →

Advanced disease

High-risk, biochemically recurrent, oligometastatic, or metastatic disease. Modern combination hormonal therapy, PSMA-guided imaging, multimodal treatment — managed by Dr. Ursiny across years, not handed off.

Advanced prostate cancer care →

What sets this practice apart.

  • High-volume robotic prostate surgeon. Outcomes from radical prostatectomy — positive-margin rates, urinary continence, erectile recovery — track strongly with annual surgeon volume. Dr. Ursiny deliberately keeps his volume high.
  • Trained at Massachusetts General Hospital / Harvard Medical School. Five years of urologic surgery residency plus the Hugh Cabot Fellowship at MGH, with subsequent faculty appointment in the MGH Department of Urology.
  • PSMA PET ordered routinely. For both staging high-risk disease and chasing a rising PSA after primary treatment, with reliable access for patients throughout Maine and New Hampshire.
  • Modern hormonal therapy managed in-house. Dr. Ursiny prescribes and follows androgen-receptor pathway agents (abiraterone, enzalutamide, apalutamide, darolutamide) himself. An in-office dispensary stocks them so prescriptions can be filled at the visit, not routed through a specialty pharmacy.
  • Genomic testing built in. Germline and tumor testing for BRCA1, BRCA2, and other DNA-repair mutations — opening the door to PARP inhibitors — for anyone with metastatic, high-risk, or recurrent disease.
  • Long-term continuity. The same physician across years. The one constant face who knows the whole story.
  • 4.9 / 5.0 across 115+ verified patient reviews.
  • Located at Fore River Urology in South Portland. Patients travel from across Maine and New Hampshire — including the Seacoast, central NH, and the Conway / White Mountains region.

Common questions.

What kind of doctor treats prostate cancer?
Most prostate cancer care is led by a urologic oncologist — a urologist who focuses on cancer of the urinary tract. This is the physician who diagnoses prostate cancer, treats it surgically when appropriate, and manages it across years. Medical oncology and radiation oncology join the team when needed. Patients often ask whether they should also see an oncologist — for most prostate cancer care, a urologic oncologist is the oncologist. Dr. Ursiny is a urologic oncologist trained at Massachusetts General Hospital and Harvard Medical School.
Do all prostate cancers need treatment?
No. Many low-risk prostate cancers are safely managed with active surveillance — careful monitoring with PSA, MRI, and periodic biopsy, treating only if the cancer shows signs of becoming more aggressive. For a substantial fraction of newly diagnosed men, this is the right answer.
Surgery or radiation — how do I choose?
Both robotic prostatectomy and radiation are effective curative treatments for localized prostate cancer. Surgery provides a surgical specimen and definitive final pathology, and keeps radiation in reserve as a future option. Radiation avoids an operation but is harder to deliver again if cancer recurs. The right answer depends on the cancer, your overall health, and your priorities — and is decided together at the consultation.
Who manages hormonal therapy if my cancer becomes advanced?
Dr. Ursiny prescribes and manages modern hormonal therapy — including androgen-receptor pathway agents such as abiraterone, enzalutamide, apalutamide, and darolutamide — himself, rather than handing patients off to medical oncology. An in-office dispensary stocks these medications so prescriptions can be filled at the visit.
Is PSMA PET imaging available?
Yes. Dr. Ursiny orders PSMA PET routinely — for staging high-risk prostate cancer and for finding recurrence after primary treatment. PSMA imaging is reliably available to patients throughout Maine and New Hampshire.
Do I need a referral?
Whether a referral is required depends on your insurance plan — some plans need one, some do not. The office can quickly confirm what your plan requires. New consultations and second opinions are welcome and typically scheduled within one to two weeks.
Schedule a Visit

Considering a consultation?

New patients and second opinions are welcome. Most consultations are scheduled within two weeks.

Book a Consultation